CH692046A5 - Derivati salini della cefalexina e loro composizioni farmaceutiche. - Google Patents

Derivati salini della cefalexina e loro composizioni farmaceutiche. Download PDF

Info

Publication number
CH692046A5
CH692046A5 CH00222/97A CH22297A CH692046A5 CH 692046 A5 CH692046 A5 CH 692046A5 CH 00222/97 A CH00222/97 A CH 00222/97A CH 22297 A CH22297 A CH 22297A CH 692046 A5 CH692046 A5 CH 692046A5
Authority
CH
Switzerland
Prior art keywords
sep
derivatives according
cel
methylol
saline
Prior art date
Application number
CH00222/97A
Other languages
English (en)
Italian (it)
Inventor
Alberto Reiner
Giorgio Reiner
Original Assignee
Apr Italia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apr Italia S R L filed Critical Apr Italia S R L
Publication of CH692046A5 publication Critical patent/CH692046A5/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH00222/97A 1996-02-02 1997-01-31 Derivati salini della cefalexina e loro composizioni farmaceutiche. CH692046A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000183A IT1282376B1 (it) 1996-02-02 1996-02-02 Derivati salini della cefalexina e loro composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
CH692046A5 true CH692046A5 (it) 2002-01-15

Family

ID=11373110

Family Applications (1)

Application Number Title Priority Date Filing Date
CH00222/97A CH692046A5 (it) 1996-02-02 1997-01-31 Derivati salini della cefalexina e loro composizioni farmaceutiche.

Country Status (3)

Country Link
KR (1) KR970061900A (ko)
CH (1) CH692046A5 (ko)
IT (1) IT1282376B1 (ko)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6064991A (ja) * 1983-09-17 1985-04-13 Fujisawa Pharmaceut Co Ltd セファレキシン・ホスミドマイシン塩およびその製造法
KR890000642B1 (ko) * 1986-06-02 1989-03-22 윤충호 가동날개를 가진 수차

Also Published As

Publication number Publication date
KR970061900A (ko) 1997-09-12
IT1282376B1 (it) 1998-03-20
ITMI960183A1 (it) 1997-08-02
ITMI960183A0 (ko) 1996-02-02

Similar Documents

Publication Publication Date Title
US20090156517A1 (en) Stable pharmaceutical compositions of aminoglycoside antibiotics, ion-chelating agents, and buffers
FI116270B (fi) Menetelmä stabiloidun prostaglandiini E1:n formulaation valmistamiseksi
UA113298C2 (xx) Композиція для догляду за порожниною рота
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
CA2657773C (en) Dental compositions comprising a phosphorylated pullulan, a cationic bactericidal agent and a solvent
KR20000068329A (ko) 약물내성 연쇄상구균 폐렴 치료용 약제 제조시의 아목시실린 및클라불라네이트의 조합물의 용도
CH667590A5 (it) Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
CN103108635A (zh) 富马酸卢帕他定的液态制剂
JPH03193735A (ja) グリコペプチド系抗生物質の安定化組成物
AU2009285632A1 (en) Compositions and methods of treatment comprising ceftaroline
CA1333775C (en) Injectable solutions containing pyridine derivatives
CA2351673A1 (en) Pharmaceutical antibacterial compositions
CH692046A5 (it) Derivati salini della cefalexina e loro composizioni farmaceutiche.
DK146435B (da) Fremgangsmaade til fremstilling af stabilt prostaglandinholdigt, frysetoerret pulver
KR102099711B1 (ko) TGF-β1 유전자의 발현을 억제하는 단일-가닥 핵산 분자를 안정적으로 함유하는 조성물
GR1009541B (el) Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν μελατονινη
JP2969002B2 (ja) 固体医薬製剤の投与剤型の製造方法
IL168257A (en) Preparations containing imidazole derivatives are converted
WO2011078832A1 (en) Effervescent formulations comprising cefixime
ITMI941169A1 (it) Formulazioni farmaceutiche
JP6471407B2 (ja) 口腔又は咽喉用組成物
CS226153B2 (en) Method of preparing new stable neutral water-soluble complexes of tetracyclin series antibiotics
WO2008026556A1 (fr) Préparation lyophilisée de 1-méthylcarbapenem
PT99447B (pt) Processo para a preparacao de composicoes anti-placa aperfeicoadas, constituidas por uma combinacao de um alcool de morfolinoamino com um agente anti-microbiano
WO2016114727A1 (en) Cefditoren pivoxil compositions with improved stability and production methods thereof

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: REAL SRL TRANSFER- APR ITALIA S.R.L.

PL Patent ceased